no was more of a speculation. But looking at presso again the meeting is still in there. So still in play but seems to be in a different order than they had discussed and
different wording used. End stage has stronger wording..
pre bla meeting for accelerated approval filing hfref.
Versus
planning to discuss if data is enough for approval for hlhs
Ann: Meeting Requested with FDA on Revascor Accelerated Approval, page-33
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.64 |
Change
-0.030(1.80%) |
Mkt cap ! $2.095B | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.67 | $1.62 | $23.20M | 14.15M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 217849 | $1.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 69336 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| MSB (ASX) Chart |